Shots: STADA acquires Lobsar and its innovative therapy to foster its footprints in specialty pharmaceuticals. The acquisition complements STADA’s portfolio and expertise in the treatment of late-stage Parkinson’s disease With […]readmore
Tags : Footprint
Shots: Aerie to acquire Avizorex (AVX) in an all-cash transaction. Avizorex to receive $10M up front, development & regulatory milestones with royalties in sales of the approved product in its […]readmore